Anzeige
Mehr »
Samstag, 18.10.2025 - Börsentäglich über 12.000 News
Denison erreicht neues 52 Wochen Hoch - Könnte ihr Joint Venture Partner Cosa der Nächste sein?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
172 Leser
Artikel bewerten:
(0)

Elsevier to Feature Award-winning Clinical Decision Support Solutions at HIMSS19

PHILADELPHIA, Feb. 7, 2019 /PRNewswire/ --

For the third year in a row, global evidence-based solution recognized in "Clinical Decision Support - Care Plans/Order Sets" category

Elsevier, the information analytics business specializing in science and health, will showcase its clinical decision support and patient engagement solutions at Booth #3331 at the Healthcare Information and Management Systems Society (HIMSS) 2019 annual meeting in Orlando, FL, USA, February 12-14, 2019.

Elsevier Logo

Elsevier's Care Planning solution was named a 2019 Category Leader for the "Clinical Decision Support - Care Plans/Order Sets" category by KLAS, the research firm which specializes in monitoring and reporting the performance of healthcare vendors.

"Elsevier leads the healthcare industry by meeting challenges and initiating solutions to assist care providers and patients," said Dr. John Danaher, President, Clinical Solutions, Elsevier. "From our award-winning Care Planning to our Via Pathways clinical decision support, both of which integrate the trusted evidence-based clinical information we are known for, we strive to support not only the referential needs but also the workflow needs of clinicians."

Other Elsevier activities at HIMSS19 include:

  • Elsevier will convene a virtual panel of informatics experts from leading healthcare organizations at its Booth #3331 on "Achieving high quality care through next generation CDS." Panelists include John Halamka, MD, MS, Chief Information Officer of Beth Israel Deaconess System; Patricia Dykes, RN, PhD, MA, Senior Scientist and Program Director for Research in the Center for Patient Safety Research and Practice at Brigham and Women's Hospital; Maria Weesner, MSN, RN, President, LIT Consulting; Richard Loomis, MD, Chief Informatics Officer, Clinical Solutions, Elsevier; and Ken Stewart, RPh, Clinical Executive, Clinical Solutions, Elsevier. To reserve your spot and receive a free gift, please go here.

  • Elsevier is sponsoring a first-of-its-kind HIMSS International CXO Dialogue on "How democratization of healthcare empowers our workforce to deliver better quality care." The workshop is on Monday, February 11, from 2-4 PM at the Orange County Convention Centre. Go here for more information and to sign up. The workshop will be moderated by Charles Alessi, Chief Clinical Officer at HIMSS, and Dr. Ian Chuang, Chief Medical Officer, Elsevier. Participants should leave the workshop with tangible outcomes and answers.

  • Elsevier will also host the Brazil Summit at HIMSS19, Room W104A, on Wednesday, February 13, from 1-7 PM. The summit will cover professional development, an essential key to advancing value-based care through a mix of presentations, and interactive panel discussions featuring international thought leadership and best practices. The summit, presented in Portuguese, will propose two perspectives, the key role of digital health professional development in advancing health systems' transformation and the shift toward value-based care.

  • Personalized Health Experience in Hall A, Booth 888, Kiosk 42, on Tuesday, February 12, from 12:45-1:05 PM, with Elsevier's Dr. Loomis presenting "Solving for Unwarranted Variation in Primary Care."

  • Innovation Live in Hall F, Booth 9000, Kiosk 27, on Tuesday, February 12, from 3:45-4:05 PM, with Mev Samarasinghe, Vice President for Search and Discovery for Healthcare, Elsevier, presenting "Towards an Integrated Healthcare Knowledge Graph."

  • Lightning Session in Hall D, Booth 7145, at the Lightning Session Theater, on Wednesday, February 13, from 12:15-12:35 PM, with James Sacra, Senior Director, Software Engineering for Precision Medicine, Elsevier, presenting "How Blockchain Failed to Meet Expectations."

  • Interoperability Showcase, Booth 9100, participating in the "Use Case: Nationwide Coordinated Care | Collaboration with Allscripts, Get Real Health, Perspecta and Veterans Affairs," with Sunish Vengathattil, Manager, Software Engineering - CDS, Elsevier, as lead presenter.

Representatives from Elsevier will be at the booth to discuss trends and topics in healthcare IT, such as patient engagement, CDS, clinical pathways, patient engagement and improving clinical outcomes.

About Elsevier

Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 38,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Media contact

Christopher Capot, Global Communications

Elsevier

+1-917-704-5174

c.capot@elsevier.com

© 2019 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.